| Dec 5, 2025 |
Dec 5, 2025 |
ENANTA PHARMACEUTICALS INC
|
Chief Scientific Officer |
Sell |
48.8
|
-2,390
|
-0.64%
|
✗
|
$34K |
| Dec 1, 2025 |
Dec 3, 2025 |
ENANTA PHARMACEUTICALS INC
|
Chief Scientific Officer |
Sell |
51.3
|
-753
|
-0.20%
|
✗
|
$10.6K |
| Feb 12, 2025 |
Feb 14, 2025 |
ENANTA PHARMACEUTICALS INC
|
Chief Scientific Officer |
Sell |
78.8
|
+5,426
|
1.47%
|
✗
|
$24.2K |
| Dec 6, 2024 |
Dec 10, 2024 |
ENANTA PHARMACEUTICALS INC
|
Chief Scientific Officer |
Sell |
48.8
|
-2,591
|
-0.70%
|
✗
|
$20.9K |
| Dec 1, 2024 |
Dec 3, 2024 |
ENANTA PHARMACEUTICALS INC
|
Chief Scientific Officer |
Sell |
51.3
|
-1,595
|
-0.43%
|
✗
|
$13.7K |
| Feb 12, 2024 |
Feb 14, 2024 |
ENANTA PHARMACEUTICALS INC
|
Chief Scientific Officer |
Sell |
68.8
|
+2,600
|
0.70%
|
✗
|
$13.4K |
| Dec 5, 2023 |
Dec 6, 2023 |
ENANTA PHARMACEUTICALS INC
|
Sr. VP, R&D & CSO |
Sell |
48.8
|
-2,412
|
-0.65%
|
✗
|
$23.2K |
| Dec 1, 2023 |
Dec 5, 2023 |
ENANTA PHARMACEUTICALS INC
|
Sr. VP, R&D & CSO |
Sell |
51.3
|
-1,595
|
-0.43%
|
✗
|
$15.1K |
| Mar 15, 2023 |
Mar 17, 2023 |
ENANTA PHARMACEUTICALS INC
|
Sr. VP & CSO |
Sell |
35.0
|
-13,925
|
-3.58%
|
✓
|
$619K |
| Feb 13, 2023 |
Feb 15, 2023 |
ENANTA PHARMACEUTICALS INC
|
Sr. VP & CSO |
Sell |
90.0
|
+15,515
|
4.32%
|
✗
|
$409.1K |
| Dec 1, 2022 |
Dec 5, 2022 |
ENANTA PHARMACEUTICALS INC
|
Sr. VP & CSO |
Sell |
51.3
|
-1,055
|
-0.29%
|
✗
|
$46.8K |
| Feb 14, 2022 |
Feb 15, 2022 |
ENANTA PHARMACEUTICALS INC
|
Sr. VP & CSO |
Sell |
72.5
|
+2,081
|
0.62%
|
✗
|
$59.6K |
| Dec 1, 2021 |
Dec 3, 2021 |
ENANTA PHARMACEUTICALS INC
|
Sr. VP & CSO |
Sell |
51.3
|
-557
|
-0.16%
|
✗
|
$48.8K |
| Dec 15, 2020 |
Dec 16, 2020 |
ENANTA PHARMACEUTICALS INC
|
Sr. VP & CSO |
Sell |
47.5
|
-1,540
|
-0.48%
|
✗
|
$65.5K |
| Feb 12, 2020 |
Feb 18, 2020 |
ENANTA PHARMACEUTICALS INC
|
Sr. VP & CSO |
Sell |
72.5
|
+2,323
|
0.77%
|
✗
|
$57.5K |
| Dec 16, 2019 |
Jan 6, 2020 |
ENANTA PHARMACEUTICALS INC
|
Sr. VP & CSO |
Sell |
45.0
|
-2,331
|
-0.76%
|
✗
|
$148.9K |
| Mar 1, 2019 |
Mar 4, 2019 |
ENANTA PHARMACEUTICALS INC
|
Sr. VP & CSO |
Sell |
32.5
|
-10,000
|
-3.22%
|
✓
|
$1M |
| Feb 11, 2019 |
Feb 13, 2019 |
ENANTA PHARMACEUTICALS INC
|
Sr. VP & CSO |
Sell |
23.8
|
-25,224
|
-7.51%
|
✓
|
$3.7M |
| Feb 12, 2018 |
Feb 13, 2018 |
ENANTA PHARMACEUTICALS INC
|
Sr. VP & CSO |
Sell |
82.5
|
+6,203
|
2.04%
|
✗
|
$204.9K |
| Feb 13, 2017 |
Feb 15, 2017 |
ENANTA PHARMACEUTICALS INC
|
Chief Scientific Officer |
Sell |
68.8
|
+1,841
|
0.61%
|
✗
|
$32.2K |
| Jan 4, 2017 |
Jan 5, 2017 |
ENANTA PHARMACEUTICALS INC
|
Chief Scientific Officer |
Sell |
35.0
|
-13,921
|
-4.41%
|
✓
|
$488.5K |
| Nov 29, 2016 |
Nov 30, 2016 |
ENANTA PHARMACEUTICALS INC
|
Chief Scientific Officer |
Sell |
20.0
|
-13,921
|
-4.22%
|
✗
|
$437.6K |
| Aug 10, 2015 |
Aug 11, 2015 |
ENANTA PHARMACEUTICALS INC
|
Chief Scientific Officer |
Sell |
45.0
|
-3,750
|
-1.77%
|
✓
|
$160.9K |
| Jul 13, 2015 |
Jul 14, 2015 |
ENANTA PHARMACEUTICALS INC
|
Chief Scientific Officer |
Sell |
45.0
|
-3,750
|
-1.74%
|
✓
|
$173.6K |
| Jun 11, 2015 |
Jun 15, 2015 |
ENANTA PHARMACEUTICALS INC
|
Chief Scientific Officer |
Sell |
45.0
|
-3,750
|
-1.71%
|
✓
|
$159.3K |
| Jun 5, 2015 |
Jun 8, 2015 |
ENANTA PHARMACEUTICALS INC
|
Chief Scientific Officer |
Sell |
35.0
|
-10,750
|
-4.67%
|
✓
|
$451.7K |
| May 11, 2015 |
May 12, 2015 |
ENANTA PHARMACEUTICALS INC
|
Chief Scientific Officer |
Sell |
35.0
|
-8,000
|
-3.36%
|
✓
|
$289K |
| Aug 13, 2014 |
Aug 15, 2014 |
ENANTA PHARMACEUTICALS INC
|
Chief Scientific Officer |
Sell |
41.3
|
-5,000
|
-2.70%
|
✓
|
$197.4K |
| Jul 1, 2014 |
Jul 3, 2014 |
ENANTA PHARMACEUTICALS INC
|
Chief Scientific Officer |
Sell |
41.3
|
-5,000
|
-2.79%
|
✓
|
$211.2K |
| Jun 2, 2014 |
Jun 4, 2014 |
ENANTA PHARMACEUTICALS INC
|
Chief Scientific Officer |
Sell |
41.3
|
-5,000
|
-2.72%
|
✓
|
$187.8K |
| May 1, 2014 |
May 2, 2014 |
ENANTA PHARMACEUTICALS INC
|
Chief Scientific Officer |
Sell |
41.3
|
-5,000
|
-2.64%
|
✓
|
$184.9K |
| Apr 1, 2014 |
Apr 2, 2014 |
ENANTA PHARMACEUTICALS INC
|
Chief Scientific Officer |
Sell |
30.0
|
-10,000
|
-5.02%
|
✓
|
$391.6K |
| Mar 24, 2014 |
Mar 25, 2014 |
ENANTA PHARMACEUTICALS INC
|
Chief Scientific Officer |
Sell |
35.0
|
-10,000
|
-4.78%
|
✓
|
$393.4K |